Home
About
Overview
Sharing Data
ORCID
Help
History (1)
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility. Blood. 2008 Aug 01; 112(3):741-9.
View in:
PubMed
subject areas
Age Factors
Female
Genetic Predisposition to Disease
Genotype
Humans
Leukemia, Myeloid
Male
Neoplasms, Second Primary
Polymorphism, Genetic
Proto-Oncogene Proteins c-mdm2
Risk Factors
Sex Factors
Tumor Suppressor Protein p53
authors with profiles
Richard A. Larson
Dezheng Huo